EUVIMEDEUVIMED entdecken
Vergleichsstudie

Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer

Kazuki Maeda, Sota Koyama, Kei Kawada, Toshinobu Hayashi, Toshihiko Yoshioka, Tomoaki Ishida, Hitoshi Fukuda, I O Horikawa, Fuka Aizawa, Takahiro Niimura, Kenta Yagi, Mitsuhiro Goda und 3 weitere

Anticancer Research · 2026

DOI: 10.21873/anticanres.18190 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Anticancer Research, 2026. Verfasst von Kazuki Maeda und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Pancreatic Neoplasms, Vomiting, Morpholines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsPancreatic NeoplasmsVomitingMorpholinesAntiemeticsColorectal NeoplasmsPyridinesHumansFemaleIrinotecanMaleRetrospective StudiesMiddle AgedOxaliplatinAgedFluorouracilLeucovorinNausea

Stichwörter der Autor:innen

AntiemeticsNK1 receptor antagonistchemotherapy-induced nausea and vomitingobservational study

Substanzen

IrinotecanOxaliplatinfosaprepitantMorpholinesAntiemeticsPyridinesFluorouracilLeucovorin

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Clinical Research Centre for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
  • Department of Clinical Pharmacy Practice Pedagogy, Tokushima University, Tokushima, Japan.
  • Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; kawada.kei@tokushima-u.ac.jp.
  • Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Department of Pharmaceutical Sciences for Health Crisis Management, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.

Zitieren

APA

Maeda, K., Koyama, S., Kawada, K., Hayashi, T., Yoshioka, T., Ishida, T., Fukuda, H., Horikawa, I. O., Aizawa, F., Niimura, T., Yagi, K., Goda, M., Izawa-Ishizawa, Y., Abe, S., & Ishizawa, K. (2026). Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18190

Vancouver

Maeda K, Koyama S, Kawada K, Hayashi T, Yoshioka T, Ishida T, et al. Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18190

BibTeX
@article{Maeda2026,
  author = {Maeda, Kazuki and Koyama, Sota and Kawada, Kei and Hayashi, Toshinobu and Yoshioka, Toshihiko and Ishida, Tomoaki and Fukuda, Hitoshi and Horikawa, I O and Aizawa, Fuka and Niimura, Takahiro and Yagi, Kenta and Goda, Mitsuhiro and Izawa-Ishizawa, Yuki and Abe, Shinji and Ishizawa, Keisuke},
  title = {Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18190}
}
Kostenlos starten →